Riskpilot← Back to searchSign inGet full accessNord Antivirus AB
ABActiveOrg 5592222300Eldaregatan 2 DRetail sale of books · NACE 4761Est. 20190 employees
Revenue 2024
SEK 728K
+197% vs 2023
EBITDA margin
0.0%
+100% vs 2023
Equity ratio
-38.5%
Financial strength
Net profit 2024
SEK 251
+100% vs 2023
| Revenue | SEK 728K | +197% |
| EBITDA | SEK 316 | +100% |
| Net profit | SEK 251 | +100% |
| Total assets | SEK 224K | +73% |
| Equity | SEK -86K | +0% |
| Employees | 0 | — |
Legal name
Nord Antivirus AB
Org number
5592222300
Legal form
Aktiebolag
NACE code
4761 · Retail sale of books
Founded
14 oktober 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva försäljning och support av programvaror inom säkerhetsområdet såsom antivirusprogram och krypteringsprogram och därmed förenlig verksamhet. Bolaget skall även äga och förvalta aktier och värdepapper samt därmed förenlig verksamhet. Bolaget skall även bedriva verksamhet inom digitala och fysiska produkter och tjänster samt förvärv av affärsverksamheter samt därmed förenlig verksamhet.
Address
Eldaregatan 2 D
Email
eskilaugustnord@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 15 | 84 | 37 | 245 | 728 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −23 | −12 | 23 | −124 | 0 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −23 | −12 | 23 | −124 | 0 |
| Net financials | — | — | — | — | — |
| Profit before tax | −23 | −12 | 23 | −124 | 0 |
| Tax | −0 | −0 | — | — | −0 |
| Net profit | −23 | −12 | 23 | −124 | 0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 49 | 37 | 73 | 129 | 224 |
| Equity | 27 | 15 | 37 | −86 | −86 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 22 | 22 | 36 | 215 | 310 |
| Total debt | 22 | 22 | 36 | 215 | 310 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
-38.5%
This company
38.2%
Market median
-201% vs market
20202024
Return on equity
25100.0%
This company
18.4%
Market median
+136313% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
3.25×
This company
1.12×
Market median
+190% vs market
20202024
Debt / equity
3.60×
This company
0.62×
Market median
-481% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-10-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EA Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nord Antivirus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eskil August Nord | Chief Executive Officer | 0 companies |
| Glenn Torgny Månsson | Deputy Board Member | 0 companies |